Latest Breaking News On - Brain metastases - Page 9 : comparemela.com

Dr Liu on the Significance of T-DXd For Patients With HER2-Mutant NSCLC and Brain Metastases

Stephen V. Liu, MD, discusses the significance of using fam-trastuzumab deruxtecan-nxki in patients with HER2-mutant non–small cell lung cancer and brain metastases according to pooled findings from exploratory analyses of the phase 2 DESTINY-Lung01 and DESTINY-Lung02 trials.

Stephenv liuGeorgetown universityGeorgetown lombardi comprehensive cancer centerThoracic oncologyDevelopmental therapeuticsOnclive tvHer2 mutantBrain metastasesT dxdTrastuzumab deruxtecan

COMING SOON: Amivantamab + Lazertinib Versus Osimertinib as 1L Treatment in EGFR-Mutated Advanced NSCLC: Primary Results From MARIPOSA

Expert oncologist Alex Spira, MD, PhD, FACP, shares his excitement for an upcoming program centered on the MARIPOSA study in advanced NSCLC following the ESMO 2023 annual meeting.

Lazertinib versus osimertinibMutated advancedPrimary results fromNon small cell lung cancerAdvanced nsclcMetastatic nsclcMariposa trialMariposa studyEgfr mutatedEgfr mutantCombination therapyNovel therapyEgfr tkiTyrosine kinase inhibitorsMet inhibitorChrysalis study

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30

Form 20-F KAZIA THERAPEUTICS LTD For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSoult ukpyolsiSouth koreaIsrael generalCity ofUnited kingdomNew south walesNew zealandSan franciscoDana farber cancer instituteNorth carolinaHong kongMemorial sloan kettering cancer centerUniversity of utahDistrict of columbia

Metixene identified as a promising candidate in the treatment of metastatic brain cancer

Metixene identified as a promising candidate in the treatment of metastatic brain cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Jawad fares at northwestern universityDrug administrationClinical investigationJawad faresNorthwestern universityTumor reductionBrain metastases

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings were presented during the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023, being held this week in San Diego, CA.

San diegoUnited statesRupesh kotechaMarkj amsbaughDavid brachmanCatherines kimBaptist health south floridaMiami cancer instituteBarrow neurological instituteGt medical technologies incNational library of medicineMemorial sloan cancer centerAmerican society for radiation oncologyGammatile therapyAmerican societyRadiation oncology